Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086150 · ClinicalTrials.gov registry record · Phase 2
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
A Phase 2 study, sponsored by Albany Medical College.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT01086150: Completed Phase 2 study, sponsored by Albany Medical College.
NCT01086150 is a Phase 2 study that has completed, run by Albany Medical College. The registered enrollment target is 51 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01086150, a Phase 2 study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent the potential progression to chronic diabetic neuropathy pain in subjects who did not report pain at the start of the study.
Primary Outcome
Scores range from 0 to 10 with higher scores indicating higher levels of pain.
Interventions
- PROCEDURE Skin biopsy
- DRUG Lidocaine 5% patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
What the finished NCT01086150 record still lists
NCT01086150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Skin biopsy is the first listed.
NCT01086150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01086150 about?
NCT01086150 is a clinical study titled "Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy". The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent th...
What is the current status of trial NCT01086150?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2009-10. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01086150?
The interventions under investigation include: Skin biopsy (PROCEDURE), Lidocaine 5% patches (DRUG).
Who is sponsoring clinical trial NCT01086150?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01086150's enrollment target sits among peer trials
51 1190th of 2000 higher than 806 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia